These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 13088693)

  • 1. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials with a new anticoagulant; tromexan].
    MILANES B; HERNANDEZ A; PEREZ STABLE E
    Rev Cubana Cardiol; 1951; 12(4):141-50. PubMed ID: 12994207
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
    AVELLANEDA M; CASTRO CM; STRITZLER G
    Cardiologia (Basel); 1953; 22(6):321-32. PubMed ID: 13082497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
    BELLER FK
    Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
    SCARRONE LA; BECK DF; WRIGHT IS
    Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
    [No Abstract]   [Full Text] [Related]  

  • 10. A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
    GRUBER CM; LEE KS; LASZICZENKO T; GRUBER CM
    Arch Int Pharmacodyn Ther; 1951 Sep; 87(4):402-12. PubMed ID: 14895202
    [No Abstract]   [Full Text] [Related]  

  • 11. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 13. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with the anticoagulant, tromexan.
    BRONSTEIN MR; WITKIND E
    Am J Med Sci; 1951 Dec; 222(6):677-85. PubMed ID: 14885211
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
    TOOHEY M
    Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tromexan therapy of thrombophlebitis].
    VUILLEUMIER P
    Praxis; 1952 Aug; 41(35):758-60. PubMed ID: 13003888
    [No Abstract]   [Full Text] [Related]  

  • 18. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate.
    CHATTERJEA JB; SALOMON L
    Br Med J; 1954 Oct; 2(4891):790-2. PubMed ID: 13199310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with tromexan].
    WICKE G
    Arztl Wochensch; 1953 Aug; 8(33):782-8. PubMed ID: 13080079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.